The resistance of cancer cells to apoptosis mediated by Bcl‐2 is a distinguishing feature of cancer; inhibition of Bcl‐2 antiapoptotic proteins will be a new way to enhance the effectiveness of chemotherapy. The gene discussed is PROS1; the disease is cancer.